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The greater use of various forms of ionizing
radiation for medical as well as non-medical
purposes is causing a rising concern over the
possible undesirable effects of these invisible
forces on the present population and upon
future generations. This increasing concern has
prompted increasing numbers of questions from
physicians, physicists, and more recently, lay
persons, concerning the upper limits in the
amount of ionizing radiation, including that
used for medical purposes, to which the general
public may be exposed with relative safety. As
a corollary to these questions the question now
arises whether adequate measures are being
taken to reduce the present radiation dose, in
particular that reaching the gonads, to the lowest
possible level.
The radiation received by the general popula-
tion as a result of medical uses of ionizing radia-
tion may be considered to come from the
following sources: (1) Diagnostic x-ray; (2) thera-
peutic x-ray and radium; and (3) radioactive
isotopes used both diagnostically and therapeu-
tically. The amount of ionizing radiation from
these sources reaching the gonadal area of pa-
tients has been either measured or estimated for
most of the procedures in which they are used,
(1—3). With the exception of Callaway, et al. (4),
and our own studies (5, 6) we know of no sys-
tematic direct measurements made of the doses
reaching the gonadal area of patients during rou-
tine dermatologic x-ray therapy. Our studies to
date have shown that the gonad dose from such
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radiation, carefully administered under varying
conditions, is usually small (7). It may, however,
under certain circumstances approach or even ex-
ceed the limits of the basic permissible weekly
doses allowed individual persons, according to the
recommendations of the responsible national
and international committees (8—10).
Our previous publications report on the gonad
dose of patients receiving routine dermatologic
therapeutic x-ray (5—7) and on special studies
carried out on patients and a pressed wood
phantom (7). The present paper, the third in the
series, deals with studies performed with a
phantom designed to investigate some of the
sources and some of the characteristics of the
radiation which may reach the gonadal area
during therapeutic dermatologic radiation, as
well as the relative effectiveness of various
shielding technics designed to reduce this gonad
dose wherever possible.
The phantom used for these studies was de-
signed to simulate a patient being treated in
one of two positions, lying horizontally on the
x-ray table, or seated by the side of the table. In
each instance the phantom occupied a similar
position (by careful measurement) to that oc-
cupied by patients undergoing treatment with
the same x-ray apparatus, table, and chair.
EQUIPMENT
Keleket K-112 pocket dosimeters with a re-
cording range from 0 to 200 milliroentgens (mr)
were used to measure the amount of radiation
reaching the gonadal area.
The pressed wood phantom was constructed to
conform to the average measurements and the
general contours of a human body. Untempered
pressed wood was used because of its comparable
density to biologic tissues. The dosimeters were
placed in the phantom in positions comparable to
the location of the testes and ovaries in men and
women respectively. For recordings at the testicu-
lar area, the dosimeters were placed between the
'legs' of the phantom, and for ovarian recordings
they were slipped into closely fitting holes in the
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Fio. 1. Diagram of the pressed wood phantom
used in these studies. Recording dosimeters were
placed at A to measure 'testicular' doses of radi-
ation, and at B to measure 'ovarian' doses.
'abdomen' of the phantom (Fig. 1). This technic
has been demonstrated to give readings satisfac-
torily close to those actually recorded by dosi-
meters placed on the skin as closely as possible to
the gonadal areas of patients during routine
therapeutic procedures (7).
The x-ray machines used were Picker Zephyr
120 'Oilflow' models. The x-ray apparatus, table,
and chair were the same for all studies, except
where otherwise stated. Details concerning the
dosimeters, the phantom, and the x-ray machines
have been given in our previous publications
(5-7).
The square sandbag used in these studies meas-
ured 11 inches on a side and 3 34 inches through
its thickest part; it weighed 16 pounds.
Shielding consisted of lead sheets 0.020 inches
(0.5 mm) thick, and lead-rubber 0.06 inches thick
(1.75 pounds per square foot). The lead-rubber, in
the form of a sheet 24 inches wide by 56 inches
long, was placed beneath the phantom at the 'hip'
level, its long axis at right angles to the long axis
of the phantom. The ends extending over the sides
of the table were then brought up and overlapped
on the 'abdomen' to enclose the 'pelvic' and 'ab-
dominal' areas in a "wrap-around" girdle of
lead-rubber sheeting (Table I, Fig. C).
PROCEDURE
Studies on the Phantom in a Horizontal Position
The phantom was placed on the table in such
a way that it simulated the body of a patient
lying horizontally. It was then "treated" with a
series of x-ray exposures to the 'head,' 'thorax,'
and 'abdomen,' each delivered according to
standard technies, and of a quality and quantity
comparable to those used in routine dermato-
logical therapeutic procedures. The target skin
distance was kept constant at 10 inches for these
studies in the horizontal position; the effective
field of radiation was 10 inches in diameter. A
dose of 170 r of unfiltered radiation at 90 kv and
7 ma, with a half value layer of 0.8 mm Al was
delivered in 58 seconds, except where otherwise
stated. For each exposure, the dosimeter readings
(representing the gonad dose or G.D.) as well as
the distance from the x-ray tube head to the
dosimeters, were carefully recorded. The first
recordings were taken on the unshielded phantom
following which three different methods of
shielding the gonadal area were used in an at-
tempt to reduce the gonad dose.
1. Efficacy of Shielding Materials:
With radiation delivered at 90 kv with an
HVL of 0.8 mm Al, 0.5 mm of lead shielding
allowed only 0.7% of the incident beam to pass
through. With the same quality radiation, the
lead-rubber sheet transmitted only 0.4% of the
incident beam.
A. Shielding Covering Phantom: The amount
of radiation leaking through the tube head, and
the peripheral portions of the primary beam
that could reach the gonadal area of the phantom
was substantially reduced by covering all of the
surface of the phantom, except for the 10 inch
field irradiated (Table I, Fig. A), with a lead
shield 0.5 mm thick. A series of exposures was
delivered along the midline of the anterior aspect
of the phantom starting at the 'head' and ex-
tending down to the 'abdomen.' The distance
from the tube head to the dosimeters was care-
fully recorded for each exposure. The results are
recorded in Table I. This method of shielding
reduced the gonad dose to an average of 64% of
the gonad dose recorded in the unshielded phan-
tom.
B. Shielding Beneath the Phantom: The lead
shield was placed beneath the full length of the
phantom (between it and the padded table top)
for the purpose of reducing any secondary radia-
tion that might arise from the table top and
structures beneath the table. This was done with
the full realization that backscatter from the
lead might add to the gonad dose (Table I, Fig.
B). It will be seen in Table I that this method of
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TABLE I
Studies on the Phantom in a Horizontal Position
Readings of the dosimeters placed in the testicular and ovarian areas of the phantom.* Comparison
of the Gonad-Dose in the unshielded phantom with readings taken with (A) lead shielding surrounding
the radiated field, (B) lead shielding placed beneath the entire phantom, and (C) a lead rubber girdle
enclosing the lower two-thirds of the phantom.
Distances From The X-Ray Tube Head to
Dosimeters
Dosimeter Readings in mc per Exposure
IJnshielded phantom
A
Lead sheet around
radiated field over
phantom
B
Lead sheet under
entire phantom
C
Lead rubber girdle
around phantom
inches
36
32
30
29
28
27
26
25
24
23
22
21.5
21
20
<2
4
5
6
8
8
9
19
25
40
80
145
185
>200
<2
<2
3
3
7
8
8
11
20
27
54
96
127
>200
<2
<2
<2
<2
5
5
7
12
22
30
73
102
141
<2
<2
<2
<2
<2
4
6
7
15
24
43
49
58
% of the Gonad-Dose in the un-
shielded phantom
100% 50—100%
(64% Avg.)
62—90%
(76% Avg.)
31—66%
(49% Avg.)
* Readings at the testicular and ovarian areas were averaged for similar tube head to dosimeter
distances. This was done for all studies in the horizontal position.
shielding reduced the gonad dose to an average
of 76% of the dose recorded in the unshielded
phantom.
C. Shielding Around Phantom—Lead-Rubber
Girdle: This technic consisted of wrapping the
lower two-thirds of the phantom in the lead-
rubber girdle (Table I, Fig. C). It proved to be
the most effective of the three methods used to
shield the gonadal area, and reduced the gonad
dose to an average of 49% of the dose recorded
in the unshielded phantom. The amount re-
corded here must be due in some part to second-
ary radiation within the phantom and in some
part to scatter.
2. Radiation of Softer Quality:
The gonadal area dose was measured again in
the unshielded phantom, this time with the use
of lower kilovoltage radiation (52 kv, 7 ma, HVL
0.6 mm Al) delivering 170 r per exposure to the
same fields as before. The results are shown in
Table II. This technic reduced the gonad dose
to an average of 20% of the dose recorded in the
El
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TABLE II
Studies on the Phantom in a Horisontal Position
Readings of the dosimeters placed in the testicu-
lar and ovarian areas of the phantom. Comparison
of the Gonad-Dose in the unshielded phantom
"treated" with 90 kilovolt radiation (HYL 0.9
mm Al) and with 52 kilovolt radiation (HVL
0.6mm Al).
% of the Gonad- 100% 17—24%
Dose produced (20% Avg.)
by 90 kv radi-
ation
unshielded phantom irradiated at 90 kv, 7 ma,
HVL 0.8 mm Al.
The Phantom in a Seated Position
The 'thighs' and 'abdomen' of the phantom
were placed in the chair alongside the table with
the dosimeters located so that they approxi-
imated the gonads of a seated patient (Fig. 2).
The position of the chair in relation to the x-ray
table and thus the primary x-ray beam was
changed by 2 or 3 inch increments through a range
of positions occupied by seated patients having
hands, wrists, or forearms treated on the adjacent
table. The x-ray beam was directed vertically at a
measured, fixed area on the fiat table surface.
The amount of radiation reaching the 'testicu-
lar' and 'ovarian' areas was first determined on
the unshielded phantom over the above men-
tioned range of distances between dosimeters
and x-ray beam (Table III). Several methods of
Fia. 2. 'Abdomen' and 'thighs' of the phantom
as used to simulate apatient in a seated position.
Dosimeters at D and E represent the testicular
and ovarian areas, respectively.
shielding were then tried, each designed to reduce
the gonadal area dose to the lowest possible
level without affecting the therapeutic efficacy
of the primary beam:
1. Restriction of the size of the field of radia-
tion. Lead shields 0.5 mm thick were placed on
the x-ray table to form a 4 inch square, the center
of which was at the axis of the vertical x-ray
beam. (A 4 inch square was chosen as repre-
sentative of the average sized area of dermatitis
irradiated on hand or forearm.) With this technic
the gonad dose was reduced to an average of 23%
of the dose recorded when there was no shielding.
The amount of radiation reaching the 'ovarian'
area was reduced somewhat more by this proce-
dure than that reaching the 'testicular' area
(Table III).
2. The sandbag placed in the field of radiation.
The sandbag was placed in the center of the
irradiated field just as it is used to support that
part of the extremity being treated in clinical
practice. As the sandbag measured 11 inches
square it filled the entire field of effective radia-
tion. With the sandbag in position, the gonad
dose was reduced to an average of 62% of the
dose recorded when the field was irradiated
without a sandbag (Table IV). When the irradi-
ated field was reduced to an area 4 inches square
by peripheral lead shielding then the addition
of the sandbag made little difference in the gonad
dose (Table IV).
Distances from the X-Ray
Tube Head to Dosimeter
Dosimeter Readings in mr per Expo
sure
90 kv radiation 52 kv radiation(HVLO.9xnmAI) (ID/LOS mAl)
inches
36
32
30
29
28
27
26
25
24
23
22
21.5
21
20
<2
4
5
6
8
8
9
19
25
40
80
145
186
>200
<2
<2
<2
<2
<2
<2
<2
<2
5
7
19
24
43
141
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TABLE III
Studies on the Phantom in a 'Seated' Position
Readings of dosimeters placed in the 'lap' (testicular) and the ovarian areas. Comparison of Gonad-
Dose with an unshielded field and with restriction of the field of radiation to a 4 inch square on the
x-ray table.
Distance From Axis Of X-Ray Beam To Dosimeter,
In Lap
Dosimeter Readings in mr per Exposure
Unrestricted (unshielded) field of
radiation
Shielding around a 4 inch field of
radiation
'Lao' (testic-
ular area) Ovarian area 'Lap' (testiculararea) ovarian area
inches
36
33
30
28
26
24
22
20
18
16
60
76
99
125
143
166
195
>200
—
—
24
29
—
44
—
60
—
—
—
—
10
16
19
31
40
40
53
65
90
110
<2
4
—
10
—
10
—
—
16
—
% of Gonad-Dose recorded in the 'lap' with
an unrestricted field of radiation
100% 35—40%
(37% Avg.)
17—28%
(23% Avg.)
% of the Gonad-Dose recorded in the 'lap'
with a restricted field of radiation
100% 18—30%
(25% Avg.)
3. Direct lead shielding of the gonadal area.
Direct shielding of the gonadal area was accom-
plished by placing a lead shield 0.5 mm thick
immediately anterior to the phantom, a proce-
dure comparable to covering the lap of a seated
patient to shield the pelvis and abdomen. Table
IV shows that this technic reduced the gonad
dose to an average of 15% of the dose recorded
without shielding. The additional shielding of the
periphery of the field of radiation, restricting it
to 4 inches, reduced the dose still further, so that
it averaged 2 to 3 per cent of the dose recorded
without either of these two technics (Table IV).
4. Softer quality radiation. With the use of
lower kiovoltage radiation (52 kv, 7 ma, HVL
0.6 mm Al) the gonad dose in the unshielded
phantom averaged 47% of the dose recorded
when 90 kv radiation with an IIVL of 0.8 mm Al
was used (Table IV). When in addition to the
softer radiation the field of radiation was re-
stricted to 4 inches, the gonad dose was reduced
to an average of 10% of the dose recorded with-
out shielding at 90 kv.
The Sources of the Radiation Constituting the
Gonadal Area Dose in the 'Seated' Phantom
As the gonadal area of the 'seated' phantom is
well outside the useful portion of the primary
beam of x-rays, the radiation reaching this area
can come either through the tube head or as
scatter from the x-ray table or other objects in
the primary beam. When the lap of the phan-
tom is very close to the table, peripheral portions
of the primary beam may irradiate the gonads.
In order to ascertain what part each of these
sources contributed to the gonad dose, a 0.5 mm
sheet of lead was interposed between the source
and the dosimeters; the standard therapeutic
dose of radiation was then delivered and the
resulting gonad dose recorded (Table V). In
Position 1, a 1 x 2 foot lead shield (0.5 mm thick)
was placed to interrupt any leakage from the
tube head or any primary beam radiation that
might reach the gonadal area directly. The shield
extended down to the upholstered surface of the
x-ray table. This technic reduced the gonad dose
to an average of 68% of the dose recorded without
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TABLE IV
Studies on the Phantom in a 'Seated' Position
Readings of the dosimeters placed in the 'lap'. Comparison of the Gonad-Dose with (1) an unshielded
phantom and unrestricted field of radiation, (2) with a sandbag placed in the irradiated field, (3) with
direct shielding of the gonadal area, (4) with low kilovoltage radiation, and finally, with restriction of
the size of the irradiated field to a 4 inch souare in combination with each of the above technics.
Horitontal Distance From the Axis of the X-Ray
Beam to the Dosimeters in 'Lap'
Dosimeter Readings in mr per Exposure
Unshielded
phantom(1)
Sandba laced in
the ¶1d of
radiation
(2)
Direct gonadal area
shielding
(3)
52 kv radiation
(HVL 0.6 mm Al)
(4)
Unrestricted field of radiation on x-ray table
inches
36
33
30
28
26
24
22
20
18
60
76
99
125
143
166
195
>200
>200
29
52
63
77
91
122
129
173
>200
4
10
22
20
19
24
34
40
56
23
34
46
56
82
78
92
106
114
% of unshielded Gonad-Dose with 90 kv
radiation
100% 48—73%
(62% Avg.)
7—21%
(15% Avg.)
39—57%
(47% Avg.)
Field of radiation restricted to a 4 inch square on the x-ray table
36
33
30
28
26
24
22
20
18
16
10
16
19
31
40
40
53
65
90
110
10
14
15
20
30
41
50
52
56
74
<2
<2
<2
4
3
4
4
8
14
21
3
6
6
8
11
20
30
34
32
50
% of unshielded Gonad-Dose with an unre-
stricted field and 90 kv radiation
17—28%
(23% Avg.)
15—25%
(19% Avg.)
2—3%
(2—3% Avg.)
5—16%
(10% Avg.)
shielding. * The same shield was then moved down
so that it extended down one foot from the
surface of the padded table along the side adja-
cent to the chair (Position 2). This procedure
reduced the scatter from the upper part of the
* It was inadvertently discovered during the
course of more recent studies, using a metal x-ray
table, that the extension of the shield in Position
1, Table V, to the metal table top (thus also
shielding the edge of the 4 inch thick upholstered
pad) reduced the gonad dose much further than
when the shield extended only down to the up-
holstered surface.
table so that the resulting gonad dose averaged
27% of the unshielded dose. A lower extension
of the same shield was then added to eliminate
the scatter from the lower part of the table and
and floor (Position 3). This made little difference
in the amount of radiation reaching the gonadal
area.
Finally, a special lead cone was devised that
fitted closely around the opening in the tube
head and extended to the table surface, (Position
4) limiting the field of radiation to an area 12
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TABLE V
Studies on the Phantom in a 'Seated' Position
Readings of the dosimeters placed in the 'lap' of the seated phantom. Comparison of the effects of lead
shielding placed in various positions designed to reduce different components of the Gonad-Dose.
Distances From the Axis of the X-Ray
Beam to Dosimeters in 'Lap' of
Phantom
Dosimeter Readings in mr per Exposure
Unshielded Shield inposition I
Shield in
position 2
Shield in
position 3
Special cone
position 4
sac/its
36
33
30
26
24
22
20
56
60
90
144
176
194
>200
30
40
66
102
120
152
>200
20
17
32
35
30
40
70
18
21
20
32
30
40
66
24
30
60
73
78
90
146
% of the Gonad-Dose in the
unshielded phantom
100% 53—75%
(68% Avg.)
21—35%
(27% Avg.)
21—35%
(25% Avg.)
44—66%
(50% Avg.)
TABLE VI
Fxa. 3. Diagrammatic representation of two po-
sitions of the sliding metal arm supporting the
x-ray tube head, that resulted in variations of the
Gonad-Dose.
inches in diameter. This reduced the gonad dose
by one-half.
During the course of these studies unexpected
variations in the recordings of the gonad dose
were discovered when the x-ray tube arm support
Studies on the Phantom in a Horizontal Position
Readings of the dosimeters placed in the tes-
ticular and ovarian areas of the phantom. Com-
parison of two positions of the x-ray tube arm
support. No shielding.
Distance from X-Ray
Tube to Dosimeter
Dosimeter Readings in mr per
Exposure
Position A Position B
inches
36 <2 <2
32 4 4
30 5 6
29 6 5
28 8 4
27 8 6
26 9 9
25 19 21
24 25 35
23 40 55
22 80 95
21.5 145 196
21 186 >200
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was placed in the two different positions illus-
trated diagrammatically in Fig. 3. The differences
in gonad dose are recorded in Table VI. It is
possible that under these circumstances there is
an increased scatter of radiation from the tube
arm in Position B as compared to Position A.
The source of the added amount of radiation
recorded in Position B was not accurately deter-
mined.
DISCUSSION
The results of our previous studies (5—7) using
these technics, demonstrated that the dosimeter
readings recorded in the phantom corresponded
quite closely with those recorded by dosimeters
placed on the skin as close as feasible to the
gonadal area of patients receiving as nearly as
possible similar amounts of radiation under simi-
lar conditions. We feel that the information gained
through the present studies on the phantom,
in general can be satisfactorily applied to the
treatment and the protection of patients. We
say this despite our recognition of the fact that
the use of the Keleket K-112 dosimeters as
recording devices is not entirely satisfactory. *
However, when the present studies were begun
there was not, to our knowledge, a more accurate
small recording instrument readily available for
use in measuring radiation in the energy range
of 50—90 kv peak.
The lead-rubber sheet wrapped as a girdle
around the phantom in a horizontal position
reduced the gonad dose from therapeutic radia-
tion to the upper chest or back by 50%. This
indicates that approximately half of the radiation
reaching the gonadal area of the phantom under
unshielded conditions apparently is from leakage
and external scatter radiation, and that the other
half is in part scatter from the primary beam,
originating within the phantom itself. Our
studies indicate that this dose can be further
reduced by using therapeutic radiation of lower
kilovoltage.
* Dosimeter readings in x-ray fields of effective
energies less than 300 kv are affected by changes in
the wavelength of the incident radiation, and the
instruments tend to record somewhat high values
for this region, down to about 50 kv. With various
recordings of x-radiation in similar kilovolt
ranges, however, the readings on these dosimeters
are strictly comparable and are therefore entirely
valid for measuring and comparing the differences
in the gonad dose effected by different methods of
shielding.
Based on the phantom studies, when patients
are treated in a seated position in a chair adjacent
to the x-ray table, the ovarian area in females
may be expected to receive less than half the
amount of radiation which will be received by
the gonadal area of a male patient, providing the
same dose and quality of radiation is adminis-
tered. Reducing the size of the irradiated field,
together with direct shielding of the gonadal
areas, is an efficient technic for reducing the
amount of ionizing radiation reaching the gonadal
area of patients treated in the seated position.
The addition of a sandbag in the field also serves
to reduce the scatter radiation. As this is a com-
monly used device for supporting a treated
extremity, it appears that it would be valuable to
study the properties of various fillings other than
sand, which might be used advantageously to
further reduce scatter radiation.
The fact that the amount of scatter radiation
reaching the gonadal area is markedly reduced
by utilizing radiation of lower kilovoltage
strengthens the present trend toward the use of
softer radiation for the treatment of numerous
dermatoses. There is little doubt but that the
use of x-radiation of softer quality will retain
essentially all of its therapeutic value (perhaps
even add some) in the treatment of the majority
of superficial dermatoses and greatly increase
the safety with which it may be used.
Approximately three-fourths of the radiation
comprising the gonad dose in a seated patient,
under the conditions of this study, originates as
scatter from the table and adjacent structures.
The remaining one-fourth comes directly through
the x-ray tube head as leakage, and/or from the
peripheral portion of the primary beam.
The fact that the specially constructed lead
cone, as used in these studies, reduced the gon-
adal area dose by approximately one-half in the
seated phantom, indicates the advantage of
having this type of attachment on all x-ray ma-
chines to be used under similar circumstances.
It decreases the gonad dose by eliminating the
peripheral or outer portions of the primary
x-ray beam. It is these portions of the primary
beam that appear to produce most of the scatter
from the table as well as being the source of
direct radiation to the gonads of patients seated
close to the table.
Because the quality of scatter radiation varies
with each x-ray apparatus and table and the
materials used in its construction, it would be
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necessary to determine the characteristics of the
scatter radiation for any given arrangement and
type of x-ray set-up. Lindell (11) has studied in
detail the nature of the scatter produced by low
kilovoltage radiation from different materials,
many of which are used in construction and
shielding of x-ray rooms and apparatus. Deter-
mination of the HVL of the scatter radiation
produced under the circumstances of these
studies was not practical with the recording
instruments used (see footnote page 244).
We feel that in general, the technics used in
these studies for the purpose of reducing the
gonad dose should prove both practical and
valuable for the following reasons: (1) they
utilize shielding materials and devices that are
readily available, inexpensive, and easily handled;
(2) the procedures are relatively speedy and
simple, and cause no discomfort or undue alarm
to the patient; (3) they are efficient in reducing
the gonad dose to such a level that the concern
now voiced over the possible genetic effects of
therapeutic radiation, at least as given for most
dermatologic disorders, may be greatly alleviated.
SUMMARY AND CONCLUSIONS
1. Measurements have been made of the
amount of ionizing radiation reaching the "gon-
adal areas" of a pressed wood phantom (compa-
rable to the Gonad Dose in patients receiving
routine dermatologic x-ray therapy under various
commonly encountered conditions).
2. The possible sources of the ionizing radia-
tion comprising the gonad dose are discussed.
3. It is demonstrated that the gonad dose
may be significantly reduced by the use of
various shielding technics and other precautions.
4. A lead-rubber sheet 0.06 inches thick (6
inch) wrapped around the lower two-thirds of
the phantom lying horizontally on the x-ray
table reduces the gonad dose by approximately
50%.
5. Reduction of the size of the irradiated field,
in combination with direct shielding of the
gonadal area, is the most effective method of
reducing the gonad dose in the seated phantom.
The dose can be reduced 97%.
6. A lead cone devised to extend from the
x-ray tube aperture to the surface being irradi-
ated and to border the field to be irradiated
reduces the gonad dose in the seated phantom
by 50%.
7. The technics recommended for reducing the
gonad dose are readily availabEe, feasible for
easy use, economical, and efficient.
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DISCUSSION
DR. ANTHONY N. DoMoNicos (New York,
N. Y.): I congratulate Dr. Stewart and his
colleagues on this wonderful piece of work. We do
need this type of work because it has been said
that dermatologists have no idea of how much
radiation they are giving and their patients have
246 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
no idea how much they are receiving. The idea
of decreasing the amount of radiation to the
gonads is mainly because of the genetic effects
that may be produced in future generations of
the patient receiving the radiation. Moreover, it
is known that we cannot measure the amount of
radiation that will cause mutation or genetic
effects because even a small amount, one-half,
one-quarter, one-eighth of a roentgen can produce
as much damage as 100r to the gonadal area.
This becomes very important in the way of
protection or shielding because there are young
children who are being treated by means of
x-ray, mainly for x-ray epilation due to T.
capitis and also for adolescents in acne vulgaris.
In these occasions it is important that proper
shielding be performed.
Dr. Andrews and I have been very much inter-
ested in this problem and our findings have been
quite similar to what Dr. Stewart and his col-
leagues have found. We covered the entire table
with lead rubber and then also covered the
patient with lead rubber. In that manner the
amount of radiation reaching the gonads was
unmeasurable. It is very important that the
tube housing be of a modern type of construction
because there is leakage of radiation. It is a
scatter type of radiation.
I would like to ask the presenters if they made
any measurements as to the quality of radiation
reaching the gonads.
The other point that should be very much
emphasized is the use of cones in giving x-ray
therapy. Today it is inexcusable not to use
protective cones to minimize scattered radiation.
I enjoyed this paper very much.
Dn. GEoRGE C. ANDREWS (New York, N. Y.):
I enjoyed hearing this paper very much. Several
points come up for discussion.
In the first place, we have no ideal ionization
chamber for measuring this gonad dose and the
Keleket Chamber and the Victoreen Chamber
really do not measure the soft radiation that is
back scatter from the floor and from the table
and that may constitute the gonad dose. Nylon
chambers or chambers made of polystyrene
fiber are preferable. However, there is no one
chamber that is ideal for this purpose.
The matter of the sitting position: I think a
lot of that radiation with a large cone, such as
shown in the picture, is probably the primary
beam. That of course can be avoided by directing
the primary beam away from the gonads. It is
very important that the primary beam always be
directed away from the gonads.
With Dr. Stewart, I agree when you have to
irradiate near the gonads, soft qualities of radia-
tion are better. We are interested in this gonad
dose in people under 30 years of age. One half of
the children are born to parents 30 years of age
or under. The other half are bornto people
under 40. So in people over 40 it does not make
much difference about the gonad dose. Those are
the people we treat for skin cancer. VThen we
treat younger people with acne of the face, we
can irradiate the face without having the gonads
get any measurable dose, not even a tenth of a
milliroentgen. We must observe ordinary pre-
cautions of putting lead rubber sheet under the
patient as well as over the patient. But the most
important is under the patient because most of
the gonad dose is a back scatter from the floor and
from the walls of the room.
There are a couple of hopeful things I heard
and that is that the rats on Eniwetok Island
bombed out 38 times by hydrogen and atomic
bombs are still there, still alive and still rats and
we hear a lot of scary things in the newspapers
about the dangers of sterility and shortness of
life of radiologists but those studies on the short-
ness of life of radiologists are being revised and
are inaccurate. Dr. Crowe at a recent meeting
showed that if the average lifespan is 70 years, it
might be shortened 20—35 days. The statistics on
leukemia in children, from pelvimetry are open
to question. The leukemia incidence in radiol-
ogists is not by any means settled. It has a lot to
do with the geographical distribution, age groups,
so forth. So there are a lot of things that we do
not know much about but we all agree that the
less radiation we give to the gonads the better.
The whole subject of the dangers of radiation
has been distorted in much of the publicity.
Dn. CLARENCE S. LIvIN000D (Detroit, Mich-
igan): I just rise to ask the presenter one question,
whether they have done any similar studies with
grenz ray.
DR. WXLLIAM D. STEWART (in closing): I
would like to thank Dr. Domonkos, Dr. Andrews
and Dr. Livingood for their comments.
Dr. Domonkos mentioned the gonad dose
from x-ray for the treatment of T. capitis of
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children. In our studies on patients at the New
York Skin and Cancer Clinic, using the Kienbock-
Adamson technic, in epilation for T. capitis, the
gonad doses received by children are really very
small, and become negligible with the use of the
protective lead rubber girdle. This is also true of
the gonad dose received from most therapeutic
dermatologic x-ray treatment to the face and the
head area. The gonad dose under these circum-
stances is really quite small.
Our studies with the lead rubber lying on the
surface of the table and then over the patient
were mentioned. We found the most satisfactory
protective method was to wrap the patient
treated in a horizontal position, in a lead rubber
girdle. This was the most effective and much the
easiest technic under our circumstances of
therapy.
I agree with the comments about the recording
chambers. I think they are probably not adequate
for obtaining the absolute values of the scatter
radiation that we are now measuring. Studies
are being done now to further evaluate the
quality of this radiation. We have no good results
yet.
We have done a few studies on the gonad dose
from grenz ray therapy. These are only rough
preliminary studies. While I would not like to
make a definite statement, we find so far, through
the range of patient positions that we have
investigated, careful use of grenz ray offers no
significant gonad dose measurable by our present
methods.
